Edmond de Rothschild Holding’s Galmed Pharmaceuticals GLMD Stock Holding History

Edmond de Rothschild Holding’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1	Closed	-$1K	–	756
2018 Q2	$1K	Sell	1 -13	-93%	-$18.8K	﹤0.01%	738
2018 Q1	$13K	Buy	+14	New	+$20.4K	﹤0.01%	724
2016 Q4	–	Sell	-5	Closed	-$4K	–	845
2016 Q3	$4K	Hold	5	–	–	﹤0.01%	816
2016 Q2	$4K	Hold	5	–	–	﹤0.01%	789
2016 Q1	$5K	Hold	5	–	–	﹤0.01%	783
2015 Q4	$7K	Hold	5	–	–	﹤0.01%	784
2015 Q3	$7K	Buy	5 +3	+150%	+$4.93K	﹤0.01%	784
2015 Q2	$4K	Buy	+2	New	+$3.48K	﹤0.01%	794

Other funds holding GLMD

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edmond de Rothschild Holding's GLMD Position: Q3 2018 in Review

Edmond de Rothschild Holding sold out of Galmed Pharmaceuticals (GLMD) in Q3 2018, closing a stake of 1 share — an estimated $1K sold.

Edmond de Rothschild Holding first reported a position in GLMD in Q2 2015 and held it in 8 quarters. The position peaked at $13K in Q1 2018. 38 funds tracked by Wall St. Rank hold GLMD as of Q3 2018.

Edmond de Rothschild Holding reported no remaining Galmed Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Edmond de Rothschild Holding sold 1 Galmed Pharmaceuticals share in Q3 2018, an estimated $1K.
Edmond de Rothschild Holding first reported a position in Galmed Pharmaceuticals in Q2 2015 and held it in 8 quarters.
Edmond de Rothschild Holding's Galmed Pharmaceuticals position peaked at $13K in Q1 2018.
38 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2018, filed 14 Nov 2018.